Overview
On October 14, the People’s Bank of China announced it would conduct a 700 billion yuan, six-month (182-day) outright reverse repo operation on October 15, 2026, via fixed-quantity rate tendering with multi-price awards, maturing April 15, 2027. With 500 billion yuan of six-month outright reverse repos maturing in October, the operation is an enlarged rollover, net-injecting 200 billion yuan. Combined with the 200 billion yuan net injection from the three-month tenor on October 8, the month’s medium-term liquidity tools have delivered a cumulative 400 billion yuan net injection — versus equal rollovers in September, signalling a clear shift from “stable” to “accommodative”.
Background & Interpretation
1. Macro and Policy Context
October is the year’s heaviest month for medium-term liquidity maturities: 1 trillion yuan of three-month outright reverse repos, 500 billion yuan of six-month, plus 900 billion yuan of MLF, totalling 2.4 trillion yuan. Meanwhile net government-bond financing is projected at 1.31–1.43 trillion yuan, concentrated in the latter half of the month, and the tax period is deferred to October 26–28. The PBOC’s early six-month injection aims to smooth cross-month volatility and support bond issuance, reflecting monetary-fiscal coordination.
2. Core Drivers and Mechanisms
Outright reverse repos and MLF are both medium-term tools, but the former offers more flexible tenors and market-priced awards that better match banks’ liability duration. As pro-growth policies intensify and 550 billion yuan of additional local-government bonds are planned for Q4, the PBOC chose enlarged rollovers over aggregate tools like cuts, filling the liquidity gap while preserving policy flexibility. Orient Securities’ Wang Qing notes that near-term RRR or rate cuts are less likely; the bank will lean on outright reverse repos and MLF to step up counter-cyclical adjustment.
3. Market Structure and Industry Impact
Money-market rates show ample liquidity: average DR001 and DR007 of 1.3117% and 1.3449% over October 8–12 both sat below the 1.4% policy rate. For bonds, the net medium-term injection eases banks’ liability pressure and supports rates; for equities, stable liquidity anchors valuations. Still, the late-October MLF-maturity and tax-period overlap remains the key window to watch.
Implications & Outlook
Late-October tax periods, MLF maturities, cross-month demand and concentrated government supply may resonate, but the magnitude and duration should remain contained. If medium-term funding and short-end injections land promptly, rates may rise briefly then ease. Resilient exports and faster fiscal spending offer further support.
Takeaways for Industry Participants
Banks and wealth managers can optimise liability duration amid falling medium-term costs; bond issuers should track government-supply rhythm to time financing; real-economy firms should lock in low-cost funding while liquidity is ample.
This column compiles industry information and shares technical perspectives; it does not constitute investment advice.